SWEDISH ORPHAN/S (OTCMKTS:SWTUY – Get Free Report)’s stock price was down 1.2% during trading on Monday . The company traded as low as $24.38 and last traded at $24.38. Approximately 200 shares traded hands during mid-day trading, a decline of 88% from the average daily volume of 1,665 shares. The stock had previously closed at $24.67.
SWEDISH ORPHAN/S Stock Performance
The stock has a market cap of $6.64 billion, a P/E ratio of 48.76, a P/E/G ratio of 1.30 and a beta of 1.81. The stock’s fifty day moving average is $24.38 and its 200 day moving average is $24.38.
About SWEDISH ORPHAN/S
Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. The company offers Elocta to treat haemophilia A; and Alprolix to treat haemophilia B.
Further Reading
- Five stocks we like better than SWEDISH ORPHAN/S
- Stock Market Upgrades: What Are They?
- High-Yield Texas Instruments Could Hit New Highs Soon
- Trading Halts Explained
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- What to Know About Investing in Penny Stocks
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for SWEDISH ORPHAN/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SWEDISH ORPHAN/S and related companies with MarketBeat.com's FREE daily email newsletter.
